BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35977490)

  • 1. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways.
    Cumin C; Huang YL; Rossdam C; Ruoff F; Céspedes SP; Liang CY; Lombardo FC; Coelho R; Rimmer N; Konantz M; López MN; Alam S; Schmidt A; Calabrese D; Fedier A; Vlajnic T; von Itzstein M; Templin M; Buettner FFR; Everest-Dass A; Heinzelmann-Schwarz V; Jacob F
    Cell Rep; 2022 Aug; 40(7):111181. PubMed ID: 35977490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition of Mesenchymal and Epithelial Cancer Cells Depends on α1-4 Galactosyltransferase-Mediated Glycosphingolipids.
    Jacob F; Alam S; Konantz M; Liang CY; Kohler RS; Everest-Dass AV; Huang YL; Rimmer N; Fedier A; Schötzau A; Lopez MN; Packer NH; Lengerke C; Heinzelmann-Schwarz V
    Cancer Res; 2018 Jun; 78(11):2952-2965. PubMed ID: 29572228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Importance of Glycosphingolipids on Cellular and Molecular Mechanisms Associated with Epithelial-to-Mesenchymal Transition in Cancer.
    Cumin C; Huang YL; Everest-Dass A; Jacob F
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33418847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.
    Liang YJ; Kuo HH; Lin CH; Chen YY; Yang BC; Cheng YY; Yu AL; Khoo KH; Yu J
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22564-9. PubMed ID: 21149694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.
    Liang YJ; Yang BC; Chen JM; Lin YH; Huang CL; Cheng YY; Hsu CY; Khoo KH; Shen CN; Yu J
    Stem Cells; 2011 Dec; 29(12):1995-2004. PubMed ID: 21956927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
    Liang YJ
    Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines.
    Guan F; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7461-6. PubMed ID: 19380734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of glycosphingolipids isolated from an epithelial ovarian cancer cell line and a nontumorigenic epithelial ovarian cell line using MALDI-MS and MALDI-MS/MS.
    Rajanayake KK; Taylor WR; Isailovic D
    Carbohydr Res; 2016 Aug; 431():6-14. PubMed ID: 27267063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor.
    Park SY; Kwak CY; Shayman JA; Kim JH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1141-8. PubMed ID: 22542783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside GD3 Regulates Inflammation and Epithelial-to-Mesenchymal Transition in Human Nasal Epithelial Cells.
    Hwang JH; Ryu JS; Yu JO; Choo YK; Kang J; Kim JY
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated transfer of neutral glycosphingolipids and ganglioside GM1 by a purified lipid transfer protein.
    Bloj B; Zilversmit DB
    J Biol Chem; 1981 Jun; 256(12):5988-91. PubMed ID: 6894595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas.
    Yu H; Zhang L; Liu P
    Tumour Biol; 2015 Mar; 36(3):1679-83. PubMed ID: 25359618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-system disorders of glycosphingolipid and ganglioside metabolism.
    Xu YH; Barnes S; Sun Y; Grabowski GA
    J Lipid Res; 2010 Jul; 51(7):1643-75. PubMed ID: 20211931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
    Müthing J; Cacić M
    Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse relationship of expression between GM3 and globo-series ganglioside in human renal cell carcinoma.
    Saito S; Nojiri H; Satoh M; Ito A; Ohyama C; Orikasa S
    Tohoku J Exp Med; 2000 Apr; 190(4):271-8. PubMed ID: 10877509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Tetsuka T; Motoyoshi K; Miura Y; Saito M
    Blood; 1984 Aug; 64(2):534-41. PubMed ID: 6589019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
    Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
    Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.